Immunotherapy of cancer using interleukin 2: current status and future prospects.
Rosenberg
S A
SA
D000818:Animals; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2